AQUALINK Trademark

Chemical substances for use in the connection of small and large molecules to antibodies for use in scientific and medical research; Chemical, biochemical and biological reagents for scientific or medical research use. Diagnostic products for scientific and medical research use in the field of antibody conjugates for scientific and medical research; Hydrophilic chemical connectors for scientific purposes, other than for medical or veterinary purposes; Antibody conjugate technology platform used to covalently attach a small or large molecule to an antibody, for scientific and medical research; Antibody technology platform incorporating hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for scientific and medical research

Antibody technology platform incorporating hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for medical diagnosis and treatment purposes; Delivery devices for antibodies, namely, drug delivery agents in the form of hydrophilic chemical connectors that facilitate the delivery and action of medical preparations; Antibody products, namely, hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for use in the fields of medical diagnosis and treatment; Chemical, biological and biochemical products for medical and pharmaceutical use, namely, hydrophilic chemical connectors; Pharmaceutical products, preparations and medical articles, namely, hydrophilic chemical connectors for medical diagnosis and disease treatment.

Research and development of hydrophilic chemical connectors; Scientific research for medical purposes in the field of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Research and development services in the field of antibodies; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research, development and establishment of testing specifications and procedures in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Providing scientific research information in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Scientific and technological services and research relating thereto, namely, research, analysis and testing in the fields of antibodies, antibody conjugates, and hydrophilic chemical connectors